Lindsay A Md Rosenwald is Director of Journey Medical Corp. Currently has a direct ownership of 144,245 shares of DERM, which is worth approximately $751,516. The most recent transaction as insider was on Mar 25, 2024, when has been sold 10,000 shares (Common Stock, $0.0001 par value) at a price of $3.04 per share, resulting in proceeds of $30,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 144K
0% 3M change
912.6% 12M change
Total Value Held $751,516

LINDSAY A MD ROSENWALD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2024
BUY
Open market or private purchase
$30,400 $3.04 p/Share
10,000 Added 6.48%
144,245 Common Stock, $0.0001 ...
Mar 22 2024
BUY
Open market or private purchase
$68,000 $3.4 p/Share
20,000 Added 12.97%
134,245 Common Stock, $0.0001 ...
Sep 06 2023
BUY
Open market or private purchase
$223,000 $2.23 p/Share
100,000 Added 46.68%
114,245 Common Stock, par valu...
Jul 21 2022
BUY
Grant, award, or other acquisition
-
14,245 Added 50.0%
14,245 Common Stock, par valu...

Also insider at

CKPT
Checkpoint Therapeutics, Inc. Healthcare
FBIO
Fortress Biotech, Inc. Healthcare
MBIO
MUSTANG BIO, INC. Healthcare
ATXI
AVENUE THERAPEUTICS, INC. Healthcare
LAM

Lindsay A Md Rosenwald

Director
Scottsdale, AZ

Track Institutional and Insider Activities on DERM

Follow Journey Medical Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DERM shares.

Notify only if

Insider Trading

Get notified when an Journey Medical Corp insider buys or sells DERM shares.

Notify only if

News

Receive news related to Journey Medical Corp

Track Activities on DERM